UK markets closed

Avinger, Inc. (AVGR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.7301-0.1199 (-3.11%)
At close: 04:00PM EDT
3.8200 +0.09 (+2.41%)
After hours: 07:48PM EDT

Avinger, Inc.

400 Chesapeake Drive
Redwood City, CA 94063
United States
(650) 241-7900
https://avinger.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees68

Key executives

NameTitlePayExercisedYear born
Mr. Jeffrey M. SoinskiPresident, CEO & Director616.79kN/A1962
Mr. Nabeel P. SubainatiVP of Finance, Principal Financial Officer & Accounting Officer347.58kN/A1984
Mr. Himanshu N. PatelChief Technology Officer430.08kN/A1960
Mr. Keith SchaeferChief Operating OfficerN/AN/AN/A
Mr. Philip R. PreussChief Marketing Officer & VP of Business OperationsN/AN/A1978
Mr. Corey GibbsVice President of SalesN/AN/AN/A
Dr. Jaafer Golzar FACC, M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Corporate governance

Avinger, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.